Benjamin Christopher Houghton

Benjamin Christopher Houghton

Auto-generated profile, based on publicly available information

Benjamin Christopher Houghton

UCL Great Ormond Street Institute of Child Health, UCL, London WC1N 1EH, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Science Translational Medicine
Verified
Journal Article
Open access
TFThomas Andrew Fox
Thomas Andrew Fox
BHBenjamin Christopher Houghton
Benjamin Christopher Houghton
LPLina Petersone
Lina Petersone
EWErin Waters
Erin Waters
NENatalie Mona Edner
Natalie Mona Edner
EMEmma Catherine Morris
Emma Catherine Morris
Heterozygous mutations in CTLA-4 result in an inborn error of immunity with an autoimmune and frequently severe clinical phenotype. Autologous T cell gene therapy may offer a cure without the immunological complications of allogeneic hematopoietic stem cell transplantation. Here, we designed a homology-directed repair (HDR) gene editing strategy that inserts the CTLA-4 cDNA into the first intron of the CTLA-4 genomic locus in primary human T cells. This resulted in regulated expression of CTLA-4 in CD4 + T cells, and functional studies demonstrated CD80 and CD86 transendocytosis. Gene editing of T cells isolated from three patients with CTLA-4 insufficiency also restored CTLA-4 protein expression and rescued transendocytosis of CD80 and CD86 in vitro. Last, gene-corrected T cells from CTLA-4 −/− mice engrafted and prevented lymphoproliferation in an in vivo murine model of CTLA-4 insufficiency. These results demonstrate the feasibility of a therapeutic approach using T cell gene therapy for CTLA-4 insufficiency.